Product Description
162401-32-3 Roflumilast API refers to the active pharmaceutical ingredient (API) of the medication roflumilast. It works by inhibiting the enzyme PDE4, which leads to increased levels of cyclic adenosine monophosphate (cAMP) in lung cells. Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor used in the treatment of severe chronic obstructive pulmonary disease (COPD). This mechanism helps reduce inflammation and relax smooth muscle in the airways, improving airflow and symptoms associated with COPD. 162401-32-3 Roflumilast API undergoes rigorous testing and quality control measures to ensure its purity, potency, and safety before being formulated into finished pharmaceutical products